These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36947133)

  • 41. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2.
    Colomer J; Gooding R; Angelicheva D; King RH; Guillén-Navarro E; Parman Y; Nascimento A; Conill J; Kalaydjieva L
    Neuromuscul Disord; 2006 Jul; 16(7):449-53. PubMed ID: 16806930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
    Barisić N; Mihatov I
    Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.
    Jennings MJ; Kagiava A; Vendredy L; Spaulding EL; Stavrou M; Hathazi D; Grüneboom A; De Winter V; Gess B; Schara U; Pogoryelova O; Lochmüller H; Borchers CH; Roos A; Burgess RW; Timmerman V; Kleopa KA; Horvath R
    Brain; 2022 Nov; 145(11):3999-4015. PubMed ID: 35148379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late Onset of Severe Demyelinating Peripheral Neuropathy in a 62-Year-Old African American Woman.
    Zivkovic SA; DiCapua D
    J Clin Neuromuscul Dis; 2024 Mar; 25(3):152-156. PubMed ID: 38441936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural history of Charcot-Marie-Tooth disease during childhood.
    Cornett KMD; Menezes MP; Shy RR; Moroni I; Pagliano E; Pareyson D; Estilow T; Yum SW; Bhandari T; Muntoni F; Laura M; Reilly MM; Finkel RS; Eichinger KJ; Herrmann DN; Bray P; Halaki M; Shy ME; Burns J;
    Ann Neurol; 2017 Sep; 82(3):353-359. PubMed ID: 28796392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotype-phenotype correlation in French patients with myelin protein zero gene-related inherited neuropathy.
    Subréville M; Bonello-Palot N; Yahiaoui D; Beloribi-Djefaflia S; Fernandes S; Stojkovic T; Cassereau J; Péréon Y; Echaniz-Laguna A; Violleau MH; Soulages A; Louis SL; Masingue M; Magot A; Delmont E; Sacconi S; Adams D; Labeyrie C; Genestet S; Noury JB; Chanson JB; Lévy N; Juntas-Morales R; Tard C; Sole G; Attarian S
    Eur J Neurol; 2021 Sep; 28(9):2913-2921. PubMed ID: 34060176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical, in silico, and experimental evidence for pathogenicity of two novel splice site mutations in the SH3TC2 gene.
    Laššuthová P; Gregor M; Sarnová L; Machalová E; Sedláček R; Seeman P
    J Neurogenet; 2012 Sep; 26(3-4):413-20. PubMed ID: 22950825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C.
    Vijay S; Chiu M; Dacks JB; Roberts RC
    Biochim Biophys Acta; 2016 Jul; 1862(7):1279-90. PubMed ID: 27068304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.
    Mannil M; Solari A; Leha A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Walter MC; Rautenstrauss B; Schnizer TJ; Schenone A; Seeman P; Kadian C; Schreiber O; Angarita NG; Fabrizi GM; Gemignani F; Padua L; Santoro L; Quattrone A; Vita G; Calabrese D; ; Young P; Laurà M; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Shy ME; Reilly MM; Pareyson D; Sereda MW
    Neuromuscul Disord; 2014 Nov; 24(11):1003-17. PubMed ID: 25085517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4.
    Nicholson G; Lenk GM; Reddel SW; Grant AE; Towne CF; Ferguson CJ; Simpson E; Scheuerle A; Yasick M; Hoffman S; Blouin R; Brandt C; Coppola G; Biesecker LG; Batish SD; Meisler MH
    Brain; 2011 Jul; 134(Pt 7):1959-71. PubMed ID: 21705420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease.
    Prada V; Robbiano G; Mennella G; Hamedani M; Bellone E; Grandis M; Schenone A; Zuccarino R
    J Peripher Nerv Syst; 2020 Dec; 25(4):413-422. PubMed ID: 33140522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy.
    Lupski JR; Reid JG; Gonzaga-Jauregui C; Rio Deiros D; Chen DC; Nazareth L; Bainbridge M; Dinh H; Jing C; Wheeler DA; McGuire AL; Zhang F; Stankiewicz P; Halperin JJ; Yang C; Gehman C; Guo D; Irikat RK; Tom W; Fantin NJ; Muzny DM; Gibbs RA
    N Engl J Med; 2010 Apr; 362(13):1181-91. PubMed ID: 20220177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review.
    Tan CA; Rabideau M; Blevins A; Westbrook MJ; Ekstein T; Nykamp K; Deucher A; Harper A; Demmer L
    Am J Med Genet A; 2016 Jun; 170(6):1580-4. PubMed ID: 26955893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations.
    Kosmanopoulos G; Donohue JK; Hoke M; Thomas S; Peyton MA; Vo L; Crawford TO; Sadjadi R; Herrmann DN; Yum SW; Reilly MM; Scherer SS; Finkel RS; Lewis RA; Pareyson D; Pisciotta C; Walk D; Shy ME; Sumner CJ; ; McCray BA
    Brain; 2024 Jun; ():. PubMed ID: 38917025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Location matters - Genotype-phenotype correlation in LRSAM1 mutations associated with rare Charcot-Marie-Tooth neuropathy CMT2P.
    Reilich P; Schlotter B; Montagnese F; Jordan B; Stock F; Schäff-Vogelsang M; Hotter B; Eger K; Diebold I; Erdmann H; Becker K; Schön U; Abicht A
    Neuromuscul Disord; 2021 Feb; 31(2):123-133. PubMed ID: 33414056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Founder SH3TC2 mutations are responsible for a CMT4C French-Canadians cluster.
    Gosselin I; Thiffault I; Tétreault M; Chau V; Dicaire MJ; Loisel L; Emond M; Senderek J; Mathieu J; Dupré N; Vanasse M; Puymirat J; Brais B
    Neuromuscul Disord; 2008 Jun; 18(6):483-92. PubMed ID: 18511281
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.